Is it possible to predict severe postpartum hemorrhage and the need for massive transfusion in placenta previa cases?
, 3, 1, 4, 5
Abstract
Objectives: The aim was to construct a reliable working model for patients with placenta previa (PP) that aids in the prediction of postpartum bleeding potential with data from antenatal imaging studies using both ultrasound (US) and magnetic resonance imaging (MRI).
Material and methods: Forty-three patients with PP were evaluated initially with the US and then by 3-Tesla MRI. The Placenta Accreata Index (PAI) was used during the US evaluation in order to define the risks. Uterine bulging, heterogeneous signal, dark placental bands, focal interruption of myometrium and tenting of bladder wall were regarded as predictive criteria in MRI evaluation. The correlation between the findings from US and MRI studies and subsequent haemorrhage, < 1000 mL, > 1000 mL and severe haemorrhage (> 2000 mL) and massive transfusion [> 5 units of red blood cells (RBC)] were used to build this predictive model. The findings from the imaging studies were also confirmed histopathologically.
Results: In the multivariate analysis of data from patients stratified by bleed size either < 1000 mL or > 1000 mL, none of the MRI and ultrasound findings were found to be predictive. The multivariate analysis was done using the second stratification cut-point of 2000 mL, in patients bleeding > 2000 mL PAI values [OR: 2.3 (1.4–3.8)] and overall MRI reported placenta accreata spectrum [OR: 4.9 (1.8–12.9)] were found to be predictive. While MRI findings were not discriminative between transfusion groups, grade 3 loculation on US examination was found to be predictive for the need of transfusion of > 5 units [OR: 67.5 (8.2–549.4)]. There were no cases needing hysterectomy.
Conclusions: Ultrasound and MRI findings in cases of PP can be helpful in predicting postpartum bleeding.
Keywords: placenta previaplacenta Accreata spectrumpostpartum haemorrhageplacenta Accreata index
References
- Fan D, Lin D, Rao J, et al. Factors and outcomes for placental anomalies: An umbrella review of systematic reviews and meta-analyses. J Glob Health. 2024; 14: 04013.
- Jenabi E, Salimi Z, Bashirian S, et al. The risk factors associated with placenta previa: An umbrella review. Placenta. 2022; 117: 21–27.
- King LJ, Dhanya Mackeen A, Nordberg C, et al. Maternal risk factors associated with persistent placenta previa. Placenta. 2020; 99: 189–192.
- Long SY, Yang Q, Chi R, et al. Maternal and neonatal outcomes resulting from antepartum hemorrhage in women with placenta previa and its associated risk factors: a single-center retrospective study. Ther Clin Risk Manag. 2021; 17: 31–38.
- Kim O, Hong S, Park InY, et al. Association between placental location and cord insertion site with pre-eclampsia: a retrospective cohort study. J Matern Fetal Neonatal Med. 2024; 37(1): 2306189.
- Pan Y, Wang Y, Miao J, et al. Risk factors for postpartum hemorrhage in severe pre-eclampsia: a retrospective single-centre study of 1953 cases. Med Sci Monit. 2024; 30: e943772.
- Wu S, Kocherginsky M, Hibbard JU. Abnormal placentation: twenty-year analysis. Am J Obstet Gynecol. 2005; 192(5): 1458–1461.
- Tantbirojn P, Crum CP, Parast MM. Pathophysiology of placenta creta: the role of decidua and extravillous trophoblast. Placenta. 2008; 29(7): 639–645.
- Silver RM, Landon MB, Rouse DJ, et al. National Institute of Child Health and Human Development Maternal-Fetal Medicine Units Network. Maternal morbidity associated with multiple repeat cesarean deliveries. Obstet Gynecol. 2006; 107(6): 1226–1232.
- Levine D, Hulka CA, Ludmir J, et al. Placenta accreta: evaluation with color Doppler US, power Doppler US, and MR imaging. Radiology. 1997; 205(3): 773–776.
- Comstock CH. Antenatal diagnosis of placenta accreta: a review. Ultrasound Obstet Gynecol. 2005; 26(1): 89–96.
- Finberg HJ, Williams JW. Placenta accreta: prospective sonographic diagnosis in patients with placenta previa and prior cesarean section. J Ultrasound Med. 1992; 11(7): 333–343.
- Pagani G, Cali G, Acharya G, et al. Diagnostic accuracy of ultrasound in detecting the severity of abnormally invasive placentation: a systematic review and meta-analysis. Acta Obstet Gynecol Scand. 2018; 97(1): 25–37.
- Kirkinen P, Helin-Martikainen HL, Vanninen R, et al. Placenta accreta: imaging by gray-scale and contrast-enhanced color Doppler sonography and magnetic resonance imaging. J Clin Ultrasound. 1998; 26(2): 90–94, doi: 10.1002/(sici)1097-0096(199802)26:2<90::aid-jcu7>3.0.co;2-d.
- De Oliveira Carniello M, Oliveira Brito LG, Sarian LO, et al. Diagnosis of placenta accreta spectrum in high-risk women using ultrasonography or magnetic resonance imaging: systematic review and meta-analysis. Ultrasound Obstet Gynecol. 2022; 59(4): 428–436.
- Jha P, Pōder L, Bourgioti C, et al. Society of Abdominal Radiology (SAR) and European Society of Urogenital Radiology (ESUR) joint consensus statement for MR imaging of placenta accreta spectrum disorders. Eur Radiol. 2020; 30(5): 2604–2615.
- Bourgioti C, Zafeiropoulou K, Fotopoulos S, et al. MRI prognosticators for adverse maternal and neonatal clinical outcome in patients at high risk for placenta accreta spectrum (PAS) disorders. J Magn Reson Imaging. 2019; 50(2): 602–618.
- International Federation of Gynecology and Obstetrics (FIGO): Recommendations on the management of postpartum haemorrhage 2022.
- RCOG: Green-top guideline for the prevention and management of postpartum haemorrhage, 2nd edition 2016.
- McCall S, Deneux‐Tharaux C, Sentilhes L, et al. Placenta accreta spectrum – variations in clinical practice and maternal morbidity between the
UK and France: a population‐based comparative study. BJOG: An International Journal of Obstetrics & Gynaecology. 2022; 129(10): 1676–1685. - Abuhamad A. Morbidly adherent placenta. Semin Perinatol. 2013; 37(5): 359–364.
- Warshak CR, Ramos GA, Eskander R, et al. Effect of predelivery diagnosis in 99 consecutive cases of placenta accreta. Obstet Gynecol. 2010; 115(1): 65–69.
- Bonnar J. Massive obstetric haemorrhage. Baillieres Best Pract Res Clin Obstet Gynaecol. 2000; 14(1): 1–18.
- Rac MWF, Dashe JS, Wells CE, et al. Ultrasound predictors of placental invasion: the Placenta Accreta Index. Am J Obstet Gynecol. 2015; 212(3): 343.e1–343.e7.
- Finazzo F, D'antonio F, Masselli G, et al. Prenatal ultrasound staging system for placenta accreta spectrum disorders. Ultrasound Obstet Gynecol. 2019; 53(6): 752–760.
- Chen T, Xu XQ, Shi HB, et al. Conventional MRI features for predicting the clinical outcome of patients with invasive placenta. Diagn Interv Radiol. 2017; 23(3): 173–179.
- Rac M, Moschos E, Wells C, et al. Sonographic findings of morbidly adherent placenta in the first trimester. J Ultrasound Med. 2016; 35(2): 263–269.
- Budorick NE, Figueroa R, Vizcarra M, et al. Another look at ultrasound and magnetic resonance imaging for diagnosis of placenta accreta. J Matern Fetal Neonatal Med. 2017; 30(20): 2422–2427.
